Ajaz Ahmad

A dedicated and skilled professional seeking to contribute my expertise in Pharmaceutical Technology, Pharmacology, Molecular Biology, and Biotechnology research and development. My aim is to leverage my comprehensive background to excel in innovative research environments. I am committed to employing my skills to their fullest potential within an organization that offers challenging opportunities and encourages professional growth. I aspire to create impactful solutions in the field and to continuously refine my technical and analytical skills. My goal is to work in a dynamic setting that fosters creativity and allows me to apply my knowledge effectively, contributing to the advancement of the organization and the broader scientific community.

Title: Professor

My research interests span a variety of critical areas within the field of pharmacy and pharmacology. I am deeply engaged in preclinical drug development, focusing on the exploration of novel therapeutic agents, assessing their efficacy, safety, and mechanisms of action, with a keen interest in bridging the gap between laboratory research and clinical application. Additionally, I am proficient in bioanalytical method development and validation, designing and implementing robust analytical methods for drug and biomarker quantification to ensure accuracy, precision, and reproducibility. My expertise also extends to pharmacokinetics and drug metabolism, where I specialize in understanding the ADME properties of drugs and optimizing drug formulations and dosing regimens. Furthermore, I utilize various animal disease models to study disease processes and evaluate the therapeutic potential of new drugs, which includes conducting in vivo studies in rodents and other species to simulate human diseases like cancer, diabetes, and cardiovascular diseases, with a focus on ethical handling and the complexities involved in translating findings from animal models to human applications. I am also committed to investigating molecular mechanisms to understand the biological processes that underpin drug actions, disease progression, and cellular responses, which informs targeted therapy development. My research in vascular pharmacology (using Myography) explores pharmacological interventions in vascular diseases, drug interactions with vascular systems, and the identification of novel therapeutic targets. Lastly, I am dedicated to sepsis research, focusing on the pathophysiology of sepsis, identifying biomarkers for early diagnosis, and developing effective therapeutic strategies to combat this complex clinical syndrome.

Teaching the CLINICAL SKILLS/Pharmacy Practice Lab-1 (PHCL-313 and 326) in the theory and lab meetings to Pharm D students. Settling and arranging exam questions, assessing students' presentations, and proctoring in the exams.

• Method for Treating Neurovascular Complication OF Diabetes Milletus, KM Alkharfy, Ghulam Mohammad, Ajaz Ahmad, MM Siddiquei, AA El-Asrar, 2019, US20170231925A1, https://patents.google.com/patent/US20170231925A1/en
• A method to relegate the adversities of beryllium stress in Capsicum annuum l. through biochar and potassium silicate, Riti Thapar Kapoor, Bilal Ahamad Paray, Ajaz Ahmad, Sheikh Mansoor, Parvaiz Ahmad, 2023, 552880, 202311044429, 2023-07-03

• Research Grants from Deanship of Scientific Research, Pharmacokinetics, pharmacodynamics and drug interaction of herbal phytoconstituents, 2015 to 2025
• Research Grant from King Abdulaziz Science and Technology, Targeting Dedifferentiation Pathways of Cancer Stem Cells: A Novel Approach for Breast Cancer Therapeutics

• Thymoquinone Mediates Müller Cell Apoptosis via miR-29b/SP1 Pathway: A Potential Therapeutic Approach in Diabetic Retinopathy, Alkharfy KM, Ahmad A, Raish M, Alenazy MF, Drug Research, 2025, 75, 02, 76-83
• The PPAR-α selective agonist WY14643 improves lupus nephritis via the downregulation of the RORγT/STAT3 signaling pathway in MRL/lpr mice, Al-Mazroua HA, Nadeem A, Attia SM, Bakheet SA, Ahmad A, Ansari MA, Ibrahim KE, Alomar HA, Almutairi MM, Algarzae NK, International Immunopharmacology, 2025, 145, 113787
• Targeting Cutaneous Leishmaniasis with Thiadiazine Thione Derivatives: An In Vivo Study of Its Anti-Inflammatory, Anti-Pyretic, Anti-Nociceptive, and Anti-Sedative Properties, Sarwar, Sarah, Nadia Sarwar, Haleema Ali, Rafiullah, Rasool Khan, Ajaz Ahmad, Amin Ullah, Ho Soonmin, Nazif Ullah, Biomedicines, 2025, 13, 1, 93
• Perspectives of pharmacy students towards academic programs accreditation: A focus on awareness, perception and attitude, Alturki M, Ahmad A, Alkharfy K, Pharmacy Education, 2024, 24, 1, 695-702
• Comparative efficiency of Geotrichum candidum microcapsules prepared with alginate and in combination with other polymers: In vitro evaluation, Amir I, Zuberi A, Kamran M, Nijabat A, Imran M, Siddiqa A, Ali A, Luna-Arias JP, Medina-Pérez G, Mashwani ZU, Ahmad A, Int J Biol Macromol, 2024, 282, Pt 2, 136901